Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Marilee McGinness et al.|Breast Cancer Research|2015Cited by 46
Neoadjuvant chemotherapy plus trastuzumab in stage II/III breast cancer with low HER2 expression.Qamar J. Khan, Priyanka Sharma, Anne O’Dea et al.|Journal of Clinical Oncology|2015Cited by 2
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionP. Thomas, Andrew K. Godwin, Moriah R. Beck et al.|UNC Libraries|2019Cited by 0
Additional file 11: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Yan Hong et al.|Figshare|2015Cited by 0
Additional file 3: of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S. Elsarraj, Fariba Behbod, Yan Hong et al.|Figshare|2015Cited by 0